Syngene acquires first US biologics facility for $36.5 million
Overall investment in the US facility is estimated around US$50 million
Overall investment in the US facility is estimated around US$50 million
This addition strengthens Dr. Agarwals Eye Hospital's vast network of 28 hospitals across Karnataka and 220+ facilities worldwide
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
Findings to form the basis for a Phase 3 program, anticipated to start in H2 2025
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
Theatre (OTs) dedicated to cataract, LASIK, and retina treatments added to meet the growing demand
Subscribe To Our Newsletter & Stay Updated